Cencora stock heads into November 4 earnings after guidance raise

Published on 10/04/2026 at 16:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cencora stock was last at USD 309.05 on October 2, 2026, after a 0.24 percent decline. Fiscal Q3 adjusted EPS beat consensus as guidance rose.

Luftbild eines modernen Pharma-Lagerzentrums mit Lieferfahrzeugen und Verladedocks — Cencora Inc. betreibt US15135B1017 ein großes Pharmadistributionszentrum mit Lastwagen Gabelstaplern und täglicher Medikamentenlogistik, Illustration mit AI erstellt.

Cencora stock (ISIN US03073E1055) was last at USD 309.05 on the NYSE on October 2, 2026, down 0.24 percent from the prior session. The company has set November 4, 2026, for its fiscal fourth-quarter results, putting its raised full-year outlook back at the center of investor attention.

November 4 sets the next test

According to Cencora on October 2, 2026, fiscal fourth-quarter results will be released before trading opens on the New York Stock Exchange, followed by an 8:30 a.m. ET conference call. That date gives investors a defined checkpoint for the company's fiscal 2027 outlook.

The scheduled report follows fiscal third-quarter figures for the period ended June 30, 2026. Cencora's fiscal calendar runs from October through September, making the November release the first full-year update under the current guidance framework.

Guidance moved above consensus

In its fiscal Q3 earnings call, Yahoo Finance reported that adjusted EPS rose 12 percent year over year to USD 4.48 in the quarter ended June 30, 2026. That result exceeded the USD 4.35 consensus, while revenue reached USD 84.8 billion, up 5 percent year over year.

Management raised fiscal 2026 adjusted EPS guidance to USD 17.75-17.95 from USD 17.70-17.90, and projected adjusted operating income growth of 13-14 percent. The call also identified a potential USD 0.35 adjusted EPS headwind if the MWI Animal Health and Covetrus transaction closes at the midpoint of fiscal 2027, making regulatory timing a concrete counter-factor.

Target sits above the last price

MarketBeat reported on October 1, 2026, that 16 brokerages carried a Moderate Buy consensus, with 13 Buy ratings and three Holds. The average 12-month price target was USD 370.85, putting the last USD 309.05 price 16.6 percent below the consensus target.

The comparison is notable because the share price remains below its 50-day moving average of USD 318.02 and its 200-day moving average of USD 303.61, both figures cited by MarketBeat on October 1, 2026. The first sits above the October 2 last price, while the second remains below it.

Stock spans USD 244.82 to USD 377.54

Cencora stock has a 52-week range of USD 244.82 to USD 377.54 as of October 2, 2026. Its market capitalization was USD 60.1 billion and trading volume was 1,161,964 shares on the same date, giving the November earnings release a clearly defined market backdrop.